arrow
K

Kamal Gupta

university of kansas
H指数:27
被引数:3,104

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients

阿司匹林用于男性和女性患者动脉粥样硬化性心血管疾病二级预防的剂量

2024-09-011
PRE
Contribution of Clinical Trial Event Data by Data Source A Prespecified Analysis of the ADAPTABLE Randomized Clinical Trial
2024-09-010
PRE
Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease

年龄和阿司匹林剂量在动脉粥样硬化性心血管疾病二级预防中的作用

2024-02-201
OAAI
Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial
2023-11-014
OAAI
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors

阿司匹林剂量用于P2Y12抑制剂治疗患者动脉粥样硬化性心血管疾病的二级预防

2023-10-171
OAAI
Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE
2023-10-010
OAAI
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE Trial

阿司匹林剂量在心血管疾病和糖尿病中的比较有效性: 适应性试验的亚组分析

2023-09-151
OAAI